Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Universkin is a French pharmaceutical company specializing in personalized, bespoke skincare solutions developed by a multidisciplinary team of dermatologists, pathologists, and biologists. The company's core business model revolves around a unique diagnostic platform that allows practitioners to create tailor-made serums containing specific active ingredients based on an individual's skin concerns. Their product line includes a wide array of pure active ingredients that can be integrated into a patented base serum, addressing indications such as inflammation, pigmentation, and skin aging. In 2022, the company was acquired by Croma-Pharma, a global leader in minimally invasive aesthetics, to enhance their portfolio of professional skincare offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Universkin.